Development of a Cell Culture Model for Inducible SARS-CoV-2 Replication
Viruses · 2024
DOI: 10.3390/v16050708 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2024. Verfasst von Xiaoyan Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences, Shanghai Institute of Infectious Disease and Biosecuri…. Hauptthemen laut MEDLINE: Virus Replication, SARS-CoV-2. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Shanghai Municipal Science and Technology Major Project, Institute of Basic Medical Sciences of the Chinese Academy of Medical Sciences.
Abstract (Originalsprache)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) induces direct cytopathic effects, complicating the establishment of low-cytotoxicity cell culture models for studying its replication. We initially developed a DNA vector-based replicon system utilizing the CMV promoter to generate a recombinant viral genome bearing reporter genes. However, this system frequently resulted in drug resistance and cytotoxicity, impeding model establishment. Herein, we present a novel cell culture model with SARS-CoV-2 replication induced by Cre/LoxP-mediated DNA recombination. An engineered SARS-CoV-2 transcription unit was subcloned into a bacterial artificial chromosome (BAC) vector. To enhance biosafety, the viral spike protein gene was deleted, and the nucleocapsid gene was replaced with a reporter gene. An exogenous sequence was inserted within NSP1 as a modulatory cassette that is removable after Cre/LoxP-mediated DNA recombination and subsequent RNA splicing. Using the PiggyBac transposon strategy, the transcription unit was integrated into host cell chromatin, yielding a stable cell line capable of inducing recombinant SARS-CoV-2 RNA replication. The model exhibited sensitivity to the potential antivirals forsythoside A and verteporfin. An innovative inducible SARS-CoV-2 replicon cell model was introduced to further explore the replication and pathogenesis of the virus and facilitate screening and assessment of anti-SARS-CoV-2 therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences, Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai 200032, China.
- Shanghai Frontiers Science Center of Pathogenic Microorganisms and Infection, Fudan University, Shanghai 200032, China.
Förderung
- National Natural Science Foundation of China
- Shanghai Municipal Science and Technology Major Project
- Institute of Basic Medical Sciences of the Chinese Academy of Medical Sciences
- Innovation Fund for Medical Sciences from Chinese Academy of Medical Sciences
Zitieren
APA
Wang, X., Zhu, Y., Wu, Q., Jiang, N., Xie, Y., & Deng, Q. (2024). Development of a Cell Culture Model for Inducible SARS-CoV-2 Replication. Viruses. https://doi.org/10.3390/v16050708
Vancouver
Wang X, Zhu Y, Wu Q, Jiang N, Xie Y, Deng Q. Development of a Cell Culture Model for Inducible SARS-CoV-2 Replication. Viruses. 2024. doi:10.3390/v16050708
BibTeX
@article{Wang2024,
author = {Wang, Xiaoyan and Zhu, Yuanfei and Wu, Qiong and Jiang, Nan and Xie, Youhua and Deng, Qiang},
title = {Development of a Cell Culture Model for Inducible SARS-CoV-2 Replication},
journal = {Viruses},
year = {2024},
doi = {10.3390/v16050708}
}
EUVIMED